Concepedia

Publication | Closed Access

A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis

DOI

54

Citations

6

References

2016

Year

Amina Jindani, Gábor Borgulya, I Westermann de Patiño, T Gonzales, Rachel Fernandes, Bhawana Shrestha, Daniel Atwine, Maryline Bonnet, M. Burgos, Faisal Dubash,
The International Journal of Tuberculosis and Lung Disease

Abstract

No significant increase in adverse events occurred when the RMP dose was increased from 10 mg/kg to 15 mg/kg or 20 mg/kg.

References

YearCitations

Page 1